SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter ...
Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...
These color-enhanced scanning electron microscope images show nanosheets resembling tiny rose petals. The nanosheets are key components of a new type of biosensor that can detect minute concentrations ...
On March 5, 2024, the US Food and Drug Administration (FDA) granted clearance to market the first over-the-counter (OTC) continuous glucose monitor (CGM). Dexcom’s Stelo Glucose Biosensor System ...
Organic hydrogels can be a promising candidate for building long-term functioning glucose biosensors
In a new study, published online in the journal American Chemical Society (ACS) Applied Polymer Materials, scientists at Texas A&M University reported they have designed a hydrogel membrane that may ...
The Nova Primary blood glucose reference analyzer meets the requirements of glucose device manufacturers and clinical researchers for an accurate, user-friendly replacement for the discontinued YSI ...
The U.S. Food and Drug Administration (FDA) has cleared the first continuous glucose monitors (CGMs) for over-the-counter sale—a major win for health freedom and common sense. "Giving more individuals ...
Daily finger-prick blood tests are an uncomfortable fact of life for diabetics, but they may not always have to be. Scientists from Canada and the US have now developed a prototype home-use device ...
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." For people with prediabetes, type 1 diabetes or type 2 diabetes, monitoring blood glucose levels is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results